论文部分内容阅读
Heart transplantation (HTx) is the only curative treatment for terminal heart disease.The short-term prognosis of HTx recipients has steadily improved in recent years: approximately 90% of patients are alive at 1 year after HTx and 50% have a life expectancy of at least 10 years.